Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

By A. Goldhirsch, J. Glick, R. Gelber, A. Coates, B. Thürlimann, H. Senn, Panel Members. Annals of Oncology, 2005

1,211 citations recorded by the source corpus.

Subfields: Cancer Research, Genetics, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/1fd96f786d8d57b70f23cab67e85ef8aaa5b124a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. M. J. van de Vijver

In Genetics

1. Andy J. Minn
2. Y. Pawitan
3. Hemant Ishwaran
4. Ulrike Grömping

In Pathology and Forensic Medicine

1. M. J. van de Vijver

Citations in the corpus

• An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer (2008, background): “ISG15 is a ubiquitin-like protein involved in posttranslational modification (10), and IFIT1 has been shown to regulate translation initiation (11).”
• Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. (2007, background): “Successive St Gallen conferences since 1978 have brought into focus contemporary insights and produced general principles based upon available evidence and expert opinion to provide guidance for the therapy of early breast cancer outside clinical trials [1].”